Department of Anesthesiology
[ Author(Asc)] Title Type Year
Filters: Keyword is Dose-Response Relationship, Drug  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Savarese JJ, Ali HH, Basta SJ, Scott RP, Embree PB, Wastila WB, Abou-Donia MM, Gelb C.  1989.  The cardiovascular effects of mivacurium chloride (BW B1090U) in patients receiving nitrous oxide-opiate-barbiturate anesthesia.. Anesthesiology. 70(3):386-94.
R
Riker WF, Okamoto M, Artusio JF.  1995.  In vivo reversal of depolarizing neuromuscular blockade.. Arch Int Pharmacodyn Ther. 330(1):90-101.
P
Pryor KO, Veselis RA, Reinsel RA, Feshchenko VA.  2004.  Enhanced visual memory effect for negative versus positive emotional content is potentiated at sub-anaesthetic concentrations of thiopental.. Br J Anaesth. 93(3):348-55.
Picollo A, Liantonio A, Didonna MPaola, Elia L, Camerino DConte, Pusch M.  2004.  Molecular determinants of differential pore blocking of kidney CLC-K chloride channels.. EMBO Rep. 5(6):584-9.
O
Ouyang W, Herold KF, Hemmings HC.  2009.  Comparative effects of halogenated inhaled anesthetics on voltage-gated Na+ channel function.. Anesthesiology. 110(3):582-90.
Okamoto M, Walewski JL, Artusio JF, Riker WF.  1992.  Neuromuscular pharmacology in rat neonates: development of responsiveness to prototypic blocking and reversal drugs.. Anesth Analg. 75(3):361-71.
N
Nimigean CM, Magleby KL.  2000.  Functional coupling of the beta(1) subunit to the large conductance Ca(2+)-activated K(+) channel in the absence of Ca(2+). Increased Ca(2+) sensitivity from a Ca(2+)-independent mechanism.. J Gen Physiol. 115(6):719-36.
Nimigean CM, Pagel MD.  2007.  Ligand binding and activation in a prokaryotic cyclic nucleotide-modulated channel.. J Mol Biol. 371(5):1325-37.
Naguib M, Lien CA, Aker J, Eliazo R.  2004.  Posttetanic potentiation and fade in the response to tetanic and train-of-four stimulation during succinylcholine-induced block.. Anesth Analg. 98(6):1686-91,tableofcontents.
M
Moss J, Rosow CE, Savarese JJ, Philbin DM, Kniffen KJ.  1981.  Role of histamine in the hypotensive action of d-tubocurarine in humans.. Anesthesiology. 55(1):19-25.
Moss J, Philbin DM, Rosow CE, Basta SJ, Gelb C, Savarese JJ.  1982.  Histamine release by neuromuscular blocking agents in man.. Klin Wochenschr. 60(17):891-5.
Moran O, Picollo A, Conti F.  2003.  Tonic and phasic guanidinium toxin-block of skeletal muscle Na channels expressed in Mammalian cells.. Biophys J. 84(5):2999-3006.
Memtsoudis SG, The AHS, Heerdt PM.  2005.  Autonomic mechanisms in the age-related hypotensive effect of propofol.. Anesth Analg. 100(1):111-5.
McCoy JG, Strawbridge C, McMurtrey KD, Kane VB, Ward CP.  2003.  A re-evaluation of the role of tetrahydropapaveroline in ethanol consumption in rats.. Brain Res Bull. 60(1-2):59-65.
Matta SG, McCoy JG, Foster CA, Sharp BM.  1995.  Nicotinic agonists administered into the fourth ventricle stimulate norepinephrine secretion in the hypothalamic paraventricular nucleus: an in vivo microdialysis study.. Neuroendocrinology. 61(4):383-92.
Martyn JA, Szyfelbein SK, Ali HH, Matteo RS, Savarese JJ.  1980.  Increased d-tubocurarine requirement following major thermal injury.. Anesthesiology. 52(4):352-5.
L
Lingameneni R, Vysotskaya TN, Duch DS, Hemmings HC.  2000.  Inhibition of voltage-dependent sodium channels by Ro 31-8220, a 'specific' protein kinase C inhibitor.. FEBS Lett. 473(2):265-8.
Lien CA.  2011.  Development and potential clinical impairment of ultra-short-acting neuromuscular blocking agents.. Br J Anaesth. 107 Suppl 1:i60-71.
Lien CA.  2010.  Neostigmine: how much is necessary for patients who receive a nondepolarizing neuromuscular blocking agent? Anesthesiology. 112(1):16-8.
Lien CA, Belmont MR, Abalos A, Eppich L, Quessy S, Abou-Donia MM, Savarese JJ.  1995.  The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia.. Anesthesiology. 82(5):1131-8.
Lebowitz PW, Ramsey FM, Savarese JJ, Ali HH.  1980.  Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine.. Anesth Analg. 59(8):604-9.
K
Kopman AF, Lien CA, Naguib M.  2011.  Neuromuscular dose-response studies: determining sample size.. Br J Anaesth. 106(2):194-8.
Kopman AF, Lien CA, Naguib M.  2010.  Determining the potency of neuromuscular blockers: are traditional methods flawed? Br J Anaesth. 104(6):705-10.
Kelly RE, Lien CA, Savarese JJ, Belmont MR, Hartman GS, Russo JR, Hollmann C.  1993.  Depression of neuromuscular function in a patient during desflurane anesthesia.. Anesth Analg. 76(4):868-71.
J
Jia F, Yue M, Chandra D, Keramidas A, Goldstein PA, Homanics GE, Harrison NL.  2008.  Taurine is a potent activator of extrasynaptic GABA(A) receptors in the thalamus.. J Neurosci. 28(1):106-15.